EGOROPAL 150 MG INJ SUS PRO ISP 1 + 2J

What is the maximum co-payment for EGOROPAL?

If the insurance company contributes, the maximum co-payment is 2 628,83 Kč. The maximum pharmacy price is 7 202,30 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does EGOROPAL have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

4 573,47 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Risperidon a paliperidon ve formě depotní injekce je hrazen u dospělých pacientů se schizofrenií s dobrou prognózou, kteří splňují všechny níže uvedené podmínky zároveň:
a) negativní skóre v dotazníku DAI-10 a je u nich potvrzena non-adherence k léčbě,
b) byli léčeni risperidonem nebo paliperidonem.
Léčba pacienta splňujícího výše uvedené je ukončena, pokud pacient relabuje během 12 měsíců od zahájení léčby risperidonem nebo paliperidonem ve formě depotní injekce, nebo pokud léčbu není možné řádně aplikovat pro pokračující nespolupráci pacienta.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe EGOROPAL?

psychiatry, child and adolescent psychiatry, geriatric psychiatry

What is the composition of EGOROPAL?

Paliperidon-palmitát (234 mg), paliperidon (150 mg), polysorbát 20, makrogol 4000, monohydrát kyseliny citronové, hydrogenfosforečnan sodný, neznámá látka s kódem 5077, solution hydroxidu sodného, voda pro injekci (1555,5 mg). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to EGOROPAL?

The medicine belongs to ATC group N05AX13 – PALIPERIDON. Medicines with the same active substance can be found here.

Who manufactures EGOROPAL?

Egis Pharmaceuticals PLC, Budapešť (H)

Is the medicine in shortage?

The latest report from the manufacturer is from 31. 12. 2025. Production was interrupted as of 31. 12. 2025. The stated reason was: Pozastavení distribuce a výdeje.
Resumption of supply is expected 30. 9. 2026
The manufacturer lists medicines with the following code as a potential substitute: